BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ocadlikova D, Lecciso M, Isidori A, Loscocco F, Visani G, Amadori S, Cavo M, Curti A. Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia. Front Oncol 2019;9:1004. [PMID: 31649875 DOI: 10.3389/fonc.2019.01004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Arimoto KI, Miyauchi S, Troutman TD, Zhang Y, Liu M, Stoner SA, Davis AG, Fan JB, Huang YJ, Yan M, Glass CK, Zhang DE. Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis. Nat Commun 2023;14:251. [PMID: 36646704 DOI: 10.1038/s41467-022-35348-5] [Reference Citation Analysis]
2 Mahdavi Sharif P, Pastaki Khoshbin A, Nasrollahzadeh E, Keshavarz-fathi M, Rezaei N. Tumor immunology. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00003-7] [Reference Citation Analysis]
3 Broecker F, Shanin E, Lysov N, Shanin V. Chemotherapy-Induced, Broadly Reactive Autoantibodies in a Colon Cancer Patient. Cureus 2022;14:e31954. [PMID: 36582563 DOI: 10.7759/cureus.31954] [Reference Citation Analysis]
4 Bao X, Xie L. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death. J Exp Clin Cancer Res 2022;41:222. [PMID: 35836249 DOI: 10.1186/s13046-022-02430-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Katifelis H, Nikou M, Mukha I, Vityuk N, Lagopati N, Piperi C, Farooqi AA, Pippa N, Efstathopoulos EP, Gazouli M. Ag/Au Bimetallic Nanoparticles Trigger Different Cell Death Pathways and Affect Damage Associated Molecular Pattern Release in Human Cell Lines. Cancers 2022;14:1546. [DOI: 10.3390/cancers14061546] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Koedijk JB, van der Werf I, Calkoen FG, Nierkens S, Kaspers GJL, Zwaan CM, Heidenreich O. Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward. Cancers (Basel) 2021;13:4364. [PMID: 34503174 DOI: 10.3390/cancers13174364] [Reference Citation Analysis]
7 Tarantini F, Cumbo C, Anelli L, Zagaria A, Specchia G, Musto P, Albano F. Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia? Cancers (Basel) 2021;13:4121. [PMID: 34439275 DOI: 10.3390/cancers13164121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Indini A, Nigro O, Lengyel CG, Ghidini M, Petrillo A, Lopez S, Raspagliesi F, Trapani D, Khakoo S, Bogani G. Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer. Cancers (Basel) 2021;13:1663. [PMID: 33916221 DOI: 10.3390/cancers13071663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Ocadlikova D, Lecciso M, Broto JM, Scotlandi K, Cavo M, Curti A, Palmerini E. Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade. Front Immunol 2021;12:577766. [PMID: 33717062 DOI: 10.3389/fimmu.2021.577766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest 2020;130:1552-64. [PMID: 32235097 DOI: 10.1172/JCI129204] [Cited by in Crossref: 61] [Cited by in F6Publishing: 71] [Article Influence: 20.3] [Reference Citation Analysis]
11 Elcheva IA, Spiegelman VS. The Role of cis- and trans-Acting RNA Regulatory Elements in Leukemia. Cancers (Basel) 2020;12:E3854. [PMID: 33419342 DOI: 10.3390/cancers12123854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
12 Ocadlikova D, Iannarone C, Redavid AR, Cavo M, Curti A. A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine. Int J Mol Sci 2020;21:E6802. [PMID: 32948017 DOI: 10.3390/ijms21186802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Res 2021;31:5-16. [PMID: 32733014 DOI: 10.1038/s41422-020-0383-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 63] [Article Influence: 17.7] [Reference Citation Analysis]
14 Schmiechen ZC, Burrack AL, Stromnes IM. Chemotherapy brings virtual memory T cells into reality for cancer therapy. Cell Mol Immunol 2021;18:1339-40. [PMID: 32620786 DOI: 10.1038/s41423-020-0496-6] [Reference Citation Analysis]